Drug
Varenicline Pill
Varenicline Pill is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
1(25%)
Results Posted
67%(2 trials)
Phase Distribution
Ph not_applicable
2
50%
Ph phase_4
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
2
Late Stage
Phase Distribution4 total trials
Phase 4Post-market surveillance
2(50.0%)
N/ANon-phased studies
2(50.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(3)
Detailed Status
Completed3
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 42 (50.0%)
N/A2 (50.0%)
Trials by Status
completed375%
recruiting125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingphase_4
E-cigarette Cessation in Adults Who Co-use Cannabis
NCT06688539
completednot_applicable
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT01511614
completedphase_4
Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
NCT04188106
completednot_applicable
So-Lo-Mo Intervention Applied to the Smoking Cessation Process
NCT03553173
Clinical Trials (4)
Showing 4 of 4 trials
NCT06688539Phase 4
E-cigarette Cessation in Adults Who Co-use Cannabis
NCT01511614Not Applicable
Nicotine Withdrawal Symptoms and Smoking Relapse
NCT04188106Phase 4
Efficacy and Tolerability of Combination Varenicline With Hydroxyzine as a Potential Smoking Cessation Treatment
NCT03553173Not Applicable
So-Lo-Mo Intervention Applied to the Smoking Cessation Process
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4